The World Health Organization has spoken: Cannabis must change positioning in the tables to regulate substances. These are the directives for the United Nations.
On January 24, the World Health Organization communicated to the Secretary-General of the United Nations. Six months exactly from the last series of recommendations aimed at avoiding that cannabidiol was entered and filed under the Single Convention on Narcotic Drugs of ’61 (SCND), the ‘World Organization for Health (WHO – World Health Organization) returns draw up guidelines for the united nations on the management of cannabis and cannabinoids.
Today, you can legally buy CBD at the shop JustBob online and in physical stores, but you can even use CBD and cannabis as medicines in some countries.
WHO position about CBD cannabis
The 41st meeting of the committee of experts on drug addiction (ECDD – Expert Committee on Drug Dependence) WHO was held, in fact, several months ago, between 12 and 16 November 2020.
The eagerly awaited presentation of the WHO recommendation to the Commission on Narcotic Drugs (CND – Commission on Narcotic Drugs) of the ‘UNit had been postponed (with no reference dates) due to the need to gather more information and review the results for longer.
It produced not a few complaints and criticisms, as in the case of the permanent representative of Uruguay at the United Nations. On the contrary, they had expressed his perplexity in the face of this delay, imagining that that delay could have influenced the choices of many countries.
But this is practically old history, and the recommendations of the World Health Organization are now on the table. As announced in the previous critical review of the ECDD, on this occasion, we talk about plant and resin, cannabis extractions and tinctures of cannabis, delta-9-THC and its isomers; a critical and in-depth review accompanies every indication of the commission on the subject, which can be consulted on the WHO website.
The panel of experts recommends first deleting cannabis and its resin from the IV table of the Single Convention on Narcotic Drugs of ’61, which contains particularly harmful substances and of extremely low medical or therapeutic value. Even extracts and tinctures should be removed from the table SCND, which lists substances of abuse and can cause health damage.
Subsequently, it is advisable to delete the II table of the Convention on Psychotropic Substances of ’71 the Dronabinol, a medicament preparation based on delta-9-tetrahydrocannabinol, to add it to the first table of the SCND, together with tetrahydrocannabinol and its isomers. The latter should be deleted from the I table of the Convention on Psychotropic Substances, which includes substances considered a risk to public health and without a recognized therapeutic value.
Finally, to implement the previous proposal, compiled during the fortieth meeting of the commission of experts on drug addiction, not to include pure CBD preparations in the international drug control conventions. Therefore, it is advisable to add a note to the first SCND table that reads: “preparations containing mainly cannabidiol and no more than 0.2% delta-9-tetrahydrocannabinol they are not under international control”.
It, therefore, should include all preparations obtained chemically or from the processing of cannabis, which is composed as pharmaceutical preparations, with one or many other ingredients and in a way that delta-9-tetracannabidiol cannot be recovered because it is directly available or with yields that may pose a risk to public health.
Besides, CBD and cannabis are known to help many patients worldwide …
Here are some of the benefits of CBD and medical cannabis
Useful against pain, spasticity and various symptoms that do not resolve with traditional drugs, medical cannabis arouses the interest of doctors, researchers and patients. In some European countries, it has been possible to resort to masterful preparations based on cannabis for medical use. For example, it has been possible to obtain a prescription for Sativex, which reduces spasticity due to multiple sclerosis.
The Ministry of Health has approved the medical use of the substance to treat, in addition to the symptoms of multiple sclerosis, also chronic pain, nausea and vomiting caused by anticancer therapies and those for HIV, disorders related to the syndrome of Gilles de la Tourette and loss of appetite due to cachexia and anorexia. On a therapeutic level, the plant can be helpful for different applications: here are its main benefits.
- CBD and multiple sclerosis
Medical cannabis is effective in treating muscle stiffness and spasticity caused by multiple sclerosis. In addition, according to several studies, using some cannabinoids can improve some of the symptoms related to this pathology.
The Ministry of Health allowed the use of medical marijuana against spasticity. In addition, it approved introducing a specific drug, Sativex, which can be prescribed with RNRL Recipe, relating to medicines subject to medical prescription, to be renewed from time to time, sold to the public on prescription from hospitals or specialists.
- Ocular health
As early as the 1970s, the results of some studies showed that medical cannabis was able to reduce intraocular pressure, a key factor for glaucoma, a disease of the optic nerve, for some time, ensuring the maintenance of ocular health.
Cannabinoids have been shown to reduce intraocular pressure when administered intravenously or by inhalation, but not when administered directly to the eye. Therefore, pills and injections of cannabinoids and the smoking of cannabis seem adequate.
So, what are you waiting for to add CBD cannabis and CBD oils to your daily routine? It is now natural and legal all thought-out the UK and Europe.
